Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaroslava Dusova

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|December 11, 2013
Re-operation of idiopathic macular hole after failed initial surgeryLibor Hejsek, Jaroslava Dusova, Alexandr Stepanov, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 28, 2023
Changes in vascular density in the macula after pars plana vitrectomy for idiopathic macular hole with macular peeling and one type of flapAnna Tarkova, Nada Jiraskova, Jaroslava Dusova, et al.
Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti|February 3, 2018
Intraoperative Optical Coherence Tomography in Vitreoretinal SurgeryJaroslava Dusova, Libor Hejsek, Alexandr Stepanov, et al.
European Journal of Ophthalmology|June 18, 2016
Microincision 25G pars plana vitrectomy with peeling of the inner limiting membrane and air tamponade in idiopathic macular holeLibor Hejsek, Alexandr Stepanov, Jaroslava Dusova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|December 4, 2012
Effects of treatment change in patients with neovascular age-related macular degeneration; results from the Czech National RegistryJan Studnicka, Eva Rencova, Pavel Rozsival, et al.
Ophthalmology and Therapy|January 31, 2026
Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized)Dorota Raczynska, Jan Ernest, Kristine Baumane, et al.
Ophthalmology and Therapy|August 29, 2025
Long-Term Efficacy and Safety of CT-P42 in Patients with Diabetic Macular Edema: 52-Week Results from a Phase 3 Randomized Clinical TrialDavid M Brown, Sebastian Wolf, Milan Veselovsky, et al.
Ophthalmology. Retina|June 28, 2024
Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III StudySebastian Wolf, Paulo-Eduardo Stanga, Milan Veselovsky, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|December 11, 2013
Re-operation of idiopathic macular hole after failed initial surgeryLibor Hejsek, Jaroslava Dusova, Alexandr Stepanov, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 28, 2023
Changes in vascular density in the macula after pars plana vitrectomy for idiopathic macular hole with macular peeling and one type of flapAnna Tarkova, Nada Jiraskova, Jaroslava Dusova, et al.
Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti|February 3, 2018
Intraoperative Optical Coherence Tomography in Vitreoretinal SurgeryJaroslava Dusova, Libor Hejsek, Alexandr Stepanov, et al.
European Journal of Ophthalmology|June 18, 2016
Microincision 25G pars plana vitrectomy with peeling of the inner limiting membrane and air tamponade in idiopathic macular holeLibor Hejsek, Alexandr Stepanov, Jaroslava Dusova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|December 4, 2012
Effects of treatment change in patients with neovascular age-related macular degeneration; results from the Czech National RegistryJan Studnicka, Eva Rencova, Pavel Rozsival, et al.
Ophthalmology and Therapy|January 31, 2026
Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized)Dorota Raczynska, Jan Ernest, Kristine Baumane, et al.
Ophthalmology and Therapy|August 29, 2025
Long-Term Efficacy and Safety of CT-P42 in Patients with Diabetic Macular Edema: 52-Week Results from a Phase 3 Randomized Clinical TrialDavid M Brown, Sebastian Wolf, Milan Veselovsky, et al.
Ophthalmology. Retina|June 28, 2024
Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III StudySebastian Wolf, Paulo-Eduardo Stanga, Milan Veselovsky, et al.
Pageof 1